At the earliest, a negotiated price for Semaglutide (Wegovy) would not be available for Medicare and Part D enrollees before 2027 and not before 2031 for Tirzepatide (Zepbound)
Both tirzepatide and semaglutide carry black box warnings about an increased risk of thyroid tumors , including a rare form of thyroid cancer (medullary thyroid carcinoma)
Zepbound single-dose vials are offered via LillyDirect and are available as a cash pay-only offering starting at $299/mo for the 2.5 mg dose
Dominiques husband is also enrolled in Virta, and theyre improving their health and vitality together
Maybe they get healthier with some weight loss, and there may be some secondary gains, George says
3 Extensively publicized reports of ocular adverse events, such as nonarteritic anterior ischemic optic neuropathy (NAION), have been challenging to assess due to confounding health factors and conflicting evidence